(August 9, 2017) The International Journal of Cancer recently published an article on preliminary findings for two factors that influence one’s risk of ovarian cancer, namely the age at which a woman gives birth and the age at which she starts using oral contraceptives. The authors, including Celeste Leigh Pearce, PhD of OCRFA’s Scientific Advisory Committee, studied data on almost 4,000 women, and found that women who had their first child after 35 had a 47% lower risk of developing ovarian cancer than women who had their first child before 25 years of age. Additionally, for every 5 years a woman waited to give birth for the first time, the risk was reduced by thirteen percent. They also found that women using oral contraceptives before the age of 35 had greater protection from ovarian cancer than those who started at a later age. Current and previous data support the fact that the effects seen from later births last for at least 30 years after the last time a woman gave birth. However, the effects seen from earlier use of oral contraceptives need further study as not all data comes to the same conclusion.
Related Topics

OCRA Sponsors NCCN 2025 Guidelines for Cervical Cancer Patients
This article was updated in May 2025 to reflect NCCN’s release of the 2025 Guidelines for Cervical Cancer Patients. OCRA is a proud sponsor of 2025 Cervical Cancer Updates. We … Continued

FDA Gives Its First-Ever Approval of Treatment for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
The Food and Drug Administration has granted accelerated approval to Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets), made by Verastem Oncology, making it the first FDA-approved treatment for patients with … Continued

OCRA’s Early Career Investigator Grant Recipients
Ovarian Cancer Research Alliance is proud to support five outstanding scientists through our Early Career Investigator Grants, part of the $6 million in new research OCRA is funding in 2025. These … Continued